Clinical performance of monolithic zirconia crowns on titanium–zirconium reduced‐diameter implants in the molar area: Interim data at three years of a randomized controlled trial
Clinical Oral Implants Research · 2023
DOI: 10.1111/clr.14179 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, 2023. Verfasst von K Zumstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Dental Porcelain, Dental Implants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinic of Reconstructive Dentistry University of Zurich, ITI Foundation.
Abstract (Originalsprache)
Aim
The aim of the present study was (i) to evaluate the clinical performance of reduced‐diameter implants placed in the molar area and (ii) to test whether monolithic zirconia implant‐supported crowns lead to similar clinical outcomes compared to porcelain‐fused‐to‐metal crowns. Materials and Methods A total of 76 patients needing a single implant crown in the posterior region were recruited. All patients received a titanium–zirconium reduced‐diameter implant (Straumann Roxolid, Tissue Level, Standard Plus, diameter 3.3 mm, regular neck) randomly allocated to receive either a (1) monolithic zirconia crown (test) or (2) porcelain‐fused‐to‐metal crown (control). Implant survival, prosthetic outcomes, and patient‐reported outcomes were assessed at crown delivery and after 3 years of follow‐up. Marginal bone levels (MBL) as well as clinical parameters including probing depth (PD), bleeding on probing (BOP), and plaque levels (PCR) were also recorded.
Results
A total of 59 patients were available at the 3‐year follow‐up; 32 patients with a monolithic zirconia crown (TEST) and 27 patients with a porcelain‐fused‐to‐metal crown (CONTROL). 14 implants (11 implant fractures/3 aseptic losses) were lost leading to an estimated implant survival rate of 80% ± 5.1% (95% CI 70.8%–90.8%). Prosthetic complications were limited to the control group and involved minor chippings.
Conclusions
This type of reduced‐diameter implant to support single implant molar crowns in the molar area cannot be recommended. Monolithic zirconia crowns appear to be a viable option in the posterior region showing similar prosthetic outcomes to porcelain‐fused‐to‐metal crowns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.
ORCID-Profile: K Zumstein, C H F Hämmerle, R E Jung, G Benic
Förderung
- Clinic of Reconstructive Dentistry University of Zurich
- ITI Foundation
Zitieren
APA
Zumstein, K., Waller, T., Hämmerle, C. H. F., Jung, R. E., Benic, G., & Mühlemann, S. (2023). Clinical performance of monolithic zirconia crowns on titanium–zirconium reduced‐diameter implants in the molar area: Interim data at three years of a randomized controlled trial. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14179
Vancouver
Zumstein K, Waller T, Hämmerle CHF, Jung RE, Benic G, Mühlemann S. Clinical performance of monolithic zirconia crowns on titanium–zirconium reduced‐diameter implants in the molar area: Interim data at three years of a randomized controlled trial. Clinical Oral Implants Research. 2023. doi:10.1111/clr.14179
BibTeX
@article{Zumstein2023,
author = {Zumstein, K and Waller, T and Hämmerle, C H F and Jung, R E and Benic, G and Mühlemann, S},
title = {Clinical performance of monolithic zirconia crowns on titanium–zirconium reduced‐diameter implants in the molar area: Interim data at three years of a randomized controlled trial},
journal = {Clinical Oral Implants Research},
year = {2023},
doi = {10.1111/clr.14179}
}
EUVIMED